ROARABLE
Today ⌘ Pro Terminal Big Ideas 🎲 Predictions Screener 🦋 Butterfly 8 Analysts 🏛️ Policy 🎬 Video ★ Watchlist 🎲 Prediction Markets 📊 RQD Track Record 📅 Next Catalysts 🛡️ Overlap & Crash X-Ray 📰 Live Wire 🐋 13F Whales 🏛️ Congress & CEO Buys 🏆 $100K Arena ⌘ Pro Terminal 📐 Methodology & Corrections
Stock Ratings / Health Care / ARDT / news
HCSG (73) SNDA (31) MD (77) BKD (32) ⌘ Pro Terminal →

Why ARDT Stock dropped -2.19% Today — RQD Quant Desk Flash

$12.03 -2.19% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $11.96

Ardent Health Inc. (ARDT) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY) →
ROARABLE C+ • HOLD / WATCH Cap $1.70B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ARDT Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ARDT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Ardent Health Inc. (NYSE: ARDT) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $12.03 (-2.19% 1D, market cap $1.70B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, ARDT ranks #85 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ARDT compare to HCSG and SNDA in the Health Care sector?
▼

Within the Health Care sector (Hospital/Nursing Management), ARDT carries a Roarable C+ (69/100 RQD), trailing P/E of 12.8x, gross margin of —, and ROIC of 10.5%. By comparison, HCSG (Healthcare Services Group Inc.) holds a B grade (73/100 RQD, P/E 28.2x, ROIC 11.6%, cap $1.65B) and SNDA (Sonida Senior Living Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC —, cap $1.65B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ARDT?
▼

Per ARDT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001756655), Ardent Health Inc. generated $6.32B in revenue (+6.0% YoY), $135.8M in net income, and $470.5M in free cash flow against $5.29B in total assets and $1.08B in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $11.96 (-0.58%)🧬 Cannibal Buyback (-1.52% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 7.4% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY • 57.3% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C+
025507510069
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk C
Cash (16)Whales (14)SEC (15)Macro (11)CEO (13)
Each axis scored 0–20
12M PRICE TARGET CONE+5% Base Target
$16 Bull$13 Base$10 Bear
📬 FREE ARDT RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ARDT)Realized 20D OHLCV Swing Band: ±7.8%
Deterministic 5-Pillar Attribution (69/100 Composite)
🔍 WHY ARDT SCORES 69/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+16/20 pts (23% of score)

SEC XBRL FY 2025 (10-K): 7.4% FCF Margin ($470.5M FCF) & 52% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (22% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Macro Regime Fit11/20 pts (-9 pt drag)

Macro rate sensitivity & RSI-14 (56) create a -9 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
61
Grade C$11.69+3.7% Next Q
Q2 (-2Q)
64
Grade C+$12.12-2.4% Next Q
Q3 (-1Q)
66
Grade B-$11.83+1.7% Next Q
Current
69
Grade C+$12.03+2% Hist 90D α
Trajectory: C (61) → C+ (69)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ARDT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 69/100 (C+) score, ARDT faces multiple-compression risk if 12.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($11.21) or 200D SMA ($10.02) invalidates the momentum regime and cuts Target Base ($12.63) toward Bear Floor ($9.85).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ARDT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ARDT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 69%NO 31%Trade / Inspect Odds →
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why ARDT Stock dropped -2.19% Today — RQD Quant Desk Flash

Ardent Health Inc. (ARDT) dropped -2.19% to $12.03, trading at 59% of its 52-week range ($7.71 – $14.99). Solid steady margins (11% return on capital), mixed timing at 13x P/E—hold if owned, no rush to chase.

  • ▸Technical Tape: Trading at 59% of its 52-week range ($7.71 – $14.99) with RSI-14 at 56 (BULLISH MOMENTUM).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±7.8% around $12.03 (no active unusual options sweep snapshot on file).
  • ▸Fundamental Anchor: Roarable C+ (Hold) backed by 52% gross margin and $470.5M annual free cash flow.
Live ARDT Headlines & Catalysts
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (ARDT Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
ARDT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +20.54%📐 HORIZONTAL RANGE
2026-11-03O $12.30H $12.30L $12.03C $12.03VOL 380.3K
RES: $12.78SUP: $9.86SMA50: $11.21SMA200: $10.02
$12.80$11.42$10.04$8.66$7.28RES $12.78SUP $9.86$12.032026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ARDT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ARDT Butterfly Map → + Track ARDT →
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
3.8%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ARDT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ARDT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ARDT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ARDT)

Health Care Rank #85 of 1016 ⚔️ HCSG vs ARDT Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ARDT vs. HCSG, SNDA, MD, BKD)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Ardent Health Inc. (ARDT) ranks #85 by composite RQD confidence (69/100, grade C+) and #280 by equity capitalization ($1.70B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with ARDT at 69/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ARDT ACTIVE
Ardent Health Inc.
C+ 69/100 12.8x — 10.5% -2.19% $1.70B Benchmark Subject
HCSG
Healthcare Services Group Inc.
B 73/100 28.2x 13.0% 11.6% -0.65% $1.65B /hcsg-vs-ardt →
SNDA
Sonida Senior Living Inc.
E 31/100 — — — +0.15% $1.65B /snda-vs-ardt →
MD
Pediatrix Medical Group Inc.
B+ 77/100 14.3x — 33.6% +2.19% $2.33B /md-vs-ardt →
BKD
Brookdale Senior Living Inc.
E 32/100 — 26.2% 0.3% +1.17% $2.48B /bkd-vs-ardt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001756655

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Ardent Health Inc. (ARDT) reported GAAP revenue of $6.32B (+6.0% vs. FY2024 revenue of $5.97B , and +16.9% cumulative change since FY2023) , GAAP net income of $135.8M, operating cash flow of $470.5M, and free cash flow of $470.5M (+49.4% YoY). On the balance sheet, ARDT closed FY2025 with $5.29B in total assets against $1.08B in total debt (Altman Z-Score: N/A, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $6.32B $135.8M $470.5M $470.5M $5.29B $1.08B
FY2024 (FY) 2024-12-31 $5.97B $210.3M $315.0M $315.0M $4.96B $1.09B
FY2023 (FY) 2023-12-31 $5.41B $53.9M $221.7M $221.7M — —

3. ARDT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ARDT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Ardent Health Inc. (NYSE: ARDT) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $12.03 (-2.19% 1D, market cap $1.70B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, ARDT ranks #85 in composite RQD confidence.

How does ARDT compare to HCSG and SNDA in the Health Care sector?

Within the Health Care sector (Hospital/Nursing Management), ARDT carries a Roarable C+ (69/100 RQD), trailing P/E of 12.8x, gross margin of —, and ROIC of 10.5%. By comparison, HCSG (Healthcare Services Group Inc.) holds a B grade (73/100 RQD, P/E 28.2x, ROIC 11.6%, cap $1.65B) and SNDA (Sonida Senior Living Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC —, cap $1.65B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ARDT?

Per ARDT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001756655), Ardent Health Inc. generated $6.32B in revenue (+6.0% YoY), $135.8M in net income, and $470.5M in free cash flow against $5.29B in total assets and $1.08B in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ARDT trading relative to its 50-day, 200-day, and 52-week technical levels?

ARDT last traded at $12.03 (-2.19% on volume of 380,281 shares), positioning the stock +7.31% above its 50-day simple moving average ($11.21) and +20.06% above its 200-day simple moving average ($10.02). Across its 52-week range of $7.71 to $14.99, ARDT sits at the 59.3% percentile with a 14-day RSI of 56.0 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.8% ($11.09 to $12.97).

Direct Sub-Reports: ARDT RQD Cockpit ARDT 12M Forecast ARDT Earnings & Move ARDT Dividends & DRIP ARDT Insiders & 13F ARDT Whale Options ARDT Profit Sankey ARDT News & Why
ROARABLE RATING BRIEF • RQD 69/100 (C+) ✓ STAGE-C NUMBER FIREWALL VERIFIED

ARDT — Ardent Health Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:27:53Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, ARDT scores 69 out of 100 (letter grade C+; verdict label "Roarable Hold — Upper Neutral / Watch for Breakout"). The five pillars are: Fundamental Cash Engine 16/20 (ROIC 10.5%; FCF yield 0%), Whale 13F Flow 14/20 (institutional accumulation and options positioning), Insider Conviction 13/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit 11/20 (beta 1.0; sector sensitivity), and Forensic Balance Sheet 15/20 (Altman Z 2.5; Piotroski F 7/9; Debt/Equity 0.84). The strongest pillar is the cash engine and balance-sheet forensics, which together support the upper-neutral framing. The weakest pillar is macro regime fit, indicating that the stock's behavior is tied to broader sector and market conditions rather than being independently driven. The FCF yield of 0% in the rating's fundamental pillar sits in tension with the positive reported FCF in the financials section, so an investor should verify how the yield is computed before weighting that pillar heavily. Valuation context from the market data (trailing P/E 12.8, forward P/E 11.9) is not directly scored by the RQD pillars. The rating reflects a "watch for breakout" stance rather than a directional buy or sell signal.

Business

Ardent Health Inc. (ARDT) is a NYSE-listed issuer in the Health Care sector, within the Hospital/Nursing Management industry. Revenue scale is reflected in the SEC financials, which report $6.32B for FY 2025. Further detail on products, payer or patient mix, and geographic footprint is —

Recent Catalysts & News Wire Analysis

  • Digital leadership transition: Several headlines reference a new digital chief and its potential effect on the stock (ARDT-rss-0, ARDT-rss-5).
  • Momentum/valuation framing: One report describes the stock as gaining 43% year-to-date and as looking like a bargain (ARDT-rss-1), and another cites a roughly 4% undervaluation estimate (ARDT-rss-5). Both are third-party characterizations.
  • Governance item (watch): A Globe and Mail report states that a former CEO termination was reclassified as "for cause" (ARDT-rss-4). This is flagged yellow in the source and warrants monitoring for any governance or legal follow-through.
  • Estimates/positioning: A TradingView estimates page and a kalkine.ca piece cover market positioning (ARDT-rss-2, ARDT-rss-3), without specific quantified claims in the summaries provided.
  • Proprietary signals: The Butterfly Supply-Chain Graph reports no supply-chain links and no proprietary signals.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, the supply chain is "NONE," with no butterfly links and no proprietary signals. Investors should note that the RQD macro-regime pillar (11/20, beta 1.0) indicates sensitivity to sector and market conditions, which is the principal second-order channel the data supports. Specific 2nd-order bottlenecks cannot be identified from the sources provided.

Open Questions

  • What is the source of the 0% FCF yield in the RQD fundamental pillar, given positive reported FCF of $470.5M for FY 2025?
  • Operating income is reported as — in all periods; what is the actual operating margin and profitability trajectory?
  • What are the specifics and timing of the digital leadership change, and how does it bear on the cost or revenue base?
  • What were the circumstances and any financial or legal consequences of the former CEO's termination for cause?
  • What is the current institutional, insider, and analyst ownership profile, given that the holders and analyst sections contain no data?

ARDT Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Ardent Health Inc. (ARDT) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ARDT Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ARDT Bull vs. Bear Conversation Board — What's Your Call at $12.03?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ARDT 🐻 50% BEARISH CONVICTION
1. Pick Your Side on ARDT:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $13.28 (+8.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is ARDT (C+ • RQD 69/100) a Buy at $12.30?

Welcome to the ARDT (Ardent Health Inc.) Roar Pit. Current RQD Composite is 69/100 (Roarable Hold — Upper Neutral / Watch for Breakout) in Hospital/Nursing Management. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RE RedlineAuditor Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $9.23 (-25.0%)
Spot @ $12.30

Pump the brakes on ARDT — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on ARDT, but look at what you are paying: 12.8x trailing P/E with tightening sector spreads. Unless Ardent Health Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MA MacroHawk_NYC Verified K Arena Trader 🐂 BULLISH 🎯 Target: $15.74 (+28.0%)
Spot @ $12.30

ARDT cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on ARDT, the market is fixating on short-term headline noise in Hospital/Nursing Management and ignoring the balance sheet and cash flow trajectory. At $12.30 (52-wk range $7.71 - $14.99), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%